What is the current price and volume for ALC.SW stock pre-market?

ALC.SW stock is at **CHF61.00** pre-market on 14 Feb 2026 with volume **1,248,030.00**, above its average volume **1,097,905.00**, signalling elevated trading interest ahead of earnings.

How does Meyka AI rate ALC.SW and what does it mean?

Meyka AI rates ALC.SW **74.79/100 (B+, BUY)**. The grade factors in benchmark and sector comparisons, growth, metrics and analyst signals. This is informational and not investment advice.

What price targets and forecasts exist for ALC.SW stock?

Meyka AI's forecast model projects monthly **CHF59.57**, quarterly **CHF61.27**, and 12-month **CHF58.39**. Short-term traders may use **CHF62.50** and bulls may target **CHF75.00**; forecasts are model-based and not guarantees.

Which catalysts should traders watch for ALC.SW stock?

Key catalysts for ALC.SW stock are the 24 Feb 2026 earnings release, updates on surgical procedure volumes, contact lens demand, and margin guidance. Regulatory notices or product changes can also move the stock.

CH Stocks

Pre-market Most Active: Alcon (ALC.SW, SIX) CHF61.00 14 Feb 2026: earnings watch

ByDanny Kontos February 14, 2026

ALC.SW stock opened pre-market at CHF61.00 on 14 Feb 2026 as trading activity picked up ahead of Alcon Inc.’s earnings note on 24 Feb 2026. Volume is elevated at 1,248,030.00 shares versus an average of 1,097,905.00, putting Alcon among the most active names on the SIX in Switzerland. Traders are weighing a middling valuation—PE 37.89 and EPS 1.61—against steady cash flow and a surgical and vision-care product mix. We outline why Alcon (ALC.SW) is active, what the numbers say, and where model forecasts place the stock